Houston, TX — Built for research institutions and venture investors

Vainture evaluates ventures across two engines — commercialization viability and patentability defensibility — in minutes.

Built for research institutions and venture investors. Houston, TX.

Run either, or run both in parallel.

2
Engines
6
Signal Dimensions
7
Prior Art Sources
Minutes
Not months

Two engines, one platform

Commercialization and patentability are distinct decision gates. We score both.

Most institutions answer these questions in different rooms, with different teams, on different timelines. Vainture runs them in parallel — independent verdicts, citation-grade evidence, in minutes.

Commercialization Engine

Vainture Signal

Should we commercialize this?

In about three minutes, we tell you whether a disclosure has real commercial legs — naming the actual market, real competitors, named investors, and likely funding sources.

Dimensions
market · competitive · regulatory · investor · partner · funding
Verdict format
Proceed / Pivot / Decline
Score
0–100 commercialization score
Runtime
~3 minutes
Built for
TTO business development · investors · founders
Try Vainture Signal →

Patentability Engine

Vainture Patent

Should we file a patent on this?

In about five minutes, we search seven prior art databases and tell you whether the invention is novel enough to defend at the patent office — with the supporting references called out.

Prior art sources
USPTO · EPO · PubMed · Semantic Scholar · arXiv · Lens · Google Patents
Verdict format
File / File narrowed / Do not file
Score
0–100 defensibility score
Runtime
~5 minutes
Built for
TTO IP counsel · patent agents · practitioners
Try Vainture Patent →

Run both in parallel

One disclosure. Both engines. Two verdicts.

Submit one disclosure. Both engines run in parallel. A unified recommendation synthesizes the two verdicts.

Unified Recommendation card coming in v1.1.

Run Full Evaluation →

Developed in collaboration with faculty across Houston's leading research institutions.

Including Baylor College of Medicine, Rice University, MD Anderson Cancer Center, and the Texas Medical Center. Designed for the decision rooms where science meets capital — and where patentability decisions move alongside commercialization decisions.